AER under FFDCA sec. 760 - nonprescription drug products

Postmarketing Adverse Drug Experience Reporting

⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0910-0230 can be found here:

Document [file]

Download: file | pdf

File Type

inode/x-empty